Company Overview

Fisher & Paykel Healthcare Corporation Limited is a New Zealand–based medical device company specializing in the design, manufacture, and global distribution of respiratory care and acute medical technologies. The company operates within the medical technology and healthcare devices industries, with a focus on products that improve patient care in hospital and home settings. Its core offerings address respiratory support, humidification, and sleep apnea therapy, serving clinicians and patients across critical care, acute care, and long-term home care environments.

The company’s primary revenue drivers are its Hospital and Homecare business segments, which include respiratory humidification systems, noninvasive ventilation products, and obstructive sleep apnea (OSA) therapy devices. Fisher & Paykel Healthcare is recognized for its proprietary humidification technology and clinician-focused product design, which together form a key strategic advantage. Founded in 1969 as a medical products division of Fisher & Paykel Industries, the company became an independent publicly listed entity in 2001 and has since evolved into one of New Zealand’s largest listed healthcare companies by market capitalization.

Business Operations

Fisher & Paykel Healthcare generates revenue through two primary operating segments: Hospital and Homecare. The Hospital segment supplies respiratory and acute care products used in intensive care units, operating theaters, emergency departments, and general wards, including humidifiers, ventilatory interfaces, and oxygen therapy systems. The Homecare segment focuses on products for the treatment of obstructive sleep apnea and chronic respiratory conditions, primarily through continuous positive airway pressure (CPAP) and related accessories.

The company designs and manufactures most of its products in-house, with significant production facilities in New Zealand and Mexico, and distribution operations spanning multiple regions. It maintains sales and marketing subsidiaries in major healthcare markets and sells products in over 120 countries. Fisher & Paykel Healthcare operates without reliance on large-scale joint ventures, instead maintaining full control over its core technologies, intellectual property, and manufacturing processes.

Strategic Position & Investments

Fisher & Paykel Healthcare’s strategic direction emphasizes organic growth through sustained investment in research and development, clinical evidence generation, and manufacturing capacity expansion. The company consistently allocates a significant portion of revenue to R&D to support incremental innovation in respiratory care and to expand clinical applications for its technologies. Its strategy prioritizes long-term value creation rather than transformational mergers or frequent acquisitions.

Major capital investments in recent years have included expanded manufacturing campuses in Auckland, New Zealand, and Tijuana, Mexico, aimed at supporting global demand growth and supply chain resilience. The company does not maintain a broad portfolio of unrelated subsidiaries or external investments; instead, it focuses on deepening its leadership in respiratory and acute care technologies and selectively advancing into adjacent clinical applications where its humidification and airflow expertise can be leveraged.

Geographic Footprint

Fisher & Paykel Healthcare is headquartered in Auckland, New Zealand, and operates globally with a strong presence across North America, Europe, Asia-Pacific, and Latin America. The United States represents its largest single market, driven by hospital respiratory care demand and a well-established distribution network. Europe and Asia-Pacific contribute significant and growing portions of revenue, supported by direct sales operations and localized clinical education teams.

Manufacturing is primarily concentrated in New Zealand and Mexico, while the company maintains sales offices, distribution centers, and service operations across multiple continents. This geographic diversification enables the company to serve both developed and emerging healthcare markets while mitigating regional demand fluctuations and supply chain risks.

Leadership & Governance

Fisher & Paykel Healthcare operates under a governance model that emphasizes clinical outcomes, ethical business practices, and long-term shareholder value. While the company does not have a single individual founder in its current form, its origins trace back to Fisher & Paykel Industries, from which it inherited a culture of engineering-led innovation. Leadership philosophy centers on sustained investment, evidence-based product development, and close collaboration with healthcare professionals.

Key members of the executive leadership team include:

• Lewis Gradon – Managing Director and Chief Executive Officer
• Tom Graney – Chief Financial Officer
• Glen Currey – Senior Vice President, Hospital
• Greg Forrest – Senior Vice President, Homecare
• Dr Andrew Somervell – Chief Technology Officer

The board and executive team collectively guide strategy with a focus on global growth, operational excellence, and maintaining the company’s position as a leading independent respiratory care technology provider.